marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q1
added 12-23-2023
Zosano Pharma Corporation Financial Ratios 2011-2024 | ZSAN
Annual Financial Ratios Zosano Pharma Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.8 | -1.1 | -0.7 | -0.6 | -0.4 | -0.5 | -0.9 | -9.0 | - | - | - |
P/S |
67.1 | 159793.7 | - | - | - | - | 83.1 | 45.0 | - | - | - |
EPS |
-0.3 | -0.5 | -2.3 | -3.7 | -16.8 | -2.2 | -2.5 | -2.8 | - | - | - |
EV (Enterprise Value) |
57 M | 25 M | 46.9 M | 28 M | 10.9 M | 17.5 M | 38.2 M | 154 M | 21.6 M | 13.6 M | - |
EBITDA per Share |
-0.27 | -0.46 | -2.23 | -3.66 | -14.9 | -37.9 | -41.9 | -16.5 | - | - | - |
EV/EBITDA |
-0.1 | -1186.0 | -0.7 | -0.6 | -0.3 | -0.5 | -1.4 | -14.7 | - | - | - |
PEG |
0.03 | 0.02 | 0.11 | -0.01 | -0.01 | -0.04 | 0.01 | 0.86 | - | - | - |
P/B |
1.6 | 0.8 | 2.7 | 1.1 | 1.6 | 3.6 | 1.0 | -9.6 | - | - | - |
P/CF |
-1.9 | -1.1 | -0.7 | -0.7 | -0.4 | -0.6 | -1.1 | -10.7 | - | - | - |
ROE % |
-90.75 | -70.23 | -400.22 | -188.98 | -412.95 | -665.15 | -107.26 | 106.27 | - | - | - |
ROA % |
-61.84 | -46.34 | -99.78 | -98.82 | -161.69 | -142.70 | -62.70 | -106.73 | - | - | - |
ROCE % |
-95.62 | -62.99 | -173.55 | -144.43 | -376.11 | -258.26 | -68.56 | 105100.00 | - | - | - |
Current Ratio |
3.1 | 2.9 | 1.3 | 2.1 | 1.3 | 1.6 | 5.4 | 0.1 | - | - | - |
DSO |
33.9 | - | - | - | - | - | 117.8 | 14.2 | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - |
DPO |
918.0 | 6659.6 | - | - | - | - | - | 5281.6 | - | - | - |
Operating Cycle |
33.9 | - | - | - | - | - | - | 14.2 | - | - | - |
Cash Conversion Cycle |
-884.1 | -6659.6 | - | - | - | - | - | -5267.4 | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Zosano Pharma Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | -7.86 | - | -0.07 | -0.06 | -2.73 | - | -0.11 | -0.14 | -0.24 | - | -0.55 | -0.55 | -0.79 | - | -0.68 | -0.75 | -4.16 | - | -0.2 | -0.17 | -6.89 | - | -0.52 | -0.54 | -0.68 | - | -0.72 | -0.63 | -0.47 | - | -0.72 | -0.76 | -0.46 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | -7.78 | - | -0.07 | -0.07 | -2.55 | - | -0.1 | -0.13 | -0.15 | - | -0.52 | -0.55 | -0.78 | - | -0.67 | -0.73 | -3.99 | - | -0.18 | -0.15 | -6.02 | - | -0.46 | -0.42 | -0.6 | - | -0.65 | -0.51 | -0.36 | - | -0.45 | -0.5 | -0.35 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-475.47 | -498.16 | -283.11 | -297.38 | -55.82 | -71.55 | -64.58 | -66.93 | -68.59 | -163.62 | -242.92 | -325.97 | -295.05 | -338.71 | -287.34 | -234.91 | -134.75 | -246.45 | -314.50 | -362.98 | -306.70 | -472.76 | -527.12 | -576.78 | -492.37 | -524.90 | -391.35 | -274.58 | -78.41 | -50.93 | 9.08 | 66.84 | 74.35 | 74.35 | 46.87 | 17.70 | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-252.67 | -268.43 | -157.86 | -167.95 | -38.25 | -49.05 | -44.08 | -50.53 | -43.05 | -69.23 | -84.62 | -92.92 | -76.05 | -98.88 | -95.53 | -95.38 | -70.46 | -114.20 | -135.11 | -147.89 | -120.09 | -155.72 | -147.60 | -141.31 | -105.63 | -124.64 | -108.03 | -93.56 | -45.84 | -73.44 | -82.03 | -94.61 | -74.68 | -74.68 | -47.07 | -17.78 | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-474.18 | -496.67 | -282.08 | -300.59 | -59.66 | -75.10 | -68.04 | -65.73 | -67.50 | -159.58 | -236.22 | -320.18 | -293.25 | -337.36 | -289.38 | -236.28 | -134.28 | -243.80 | -309.21 | -355.10 | -298.21 | -457.28 | -506.82 | -553.20 | -472.26 | -503.76 | -376.18 | -262.09 | -72.39 | -49.21 | 5.47 | 55.94 | 67.58 | 67.58 | 44.40 | 19.16 | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | 2.1 | 3.1 | 3.3 | 3.4 | 2.9 | 2.9 | 3.2 | 1.6 | 1.8 | 1.3 | 1.3 | 1.3 | 1.3 | 2.1 | 2.1 | 2.1 | 2.1 | 1.6 | 1.6 | 1.6 | 1.6 | 1.3 | 1.3 | 1.3 | 1.3 | 2.4 | 2.4 | 2.4 | 2.4 | 0.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | 81.9 | - | 33.3 | 65.5 | 15.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 79.7 | 53.0 | - | 27.1 | 20.0 | 3.2 | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | 3098.3 | - | 433.2 | 979.8 | 1280.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | 81.9 | - | 33.3 | 65.5 | 15.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 79.7 | 53.0 | - | 27.1 | 20.0 | 3.2 | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | -3016.3 | - | -399.9 | -914.3 | -1264.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 79.7 | 53.0 | - | 27.1 | 20.0 | 3.2 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency